Filip de Vos

Assistant Professor - medical

Strategic program(s):

Biography

Education

1993 – 1996

1996 – 2000

2004

2010

Pre-MedicalSchool at Limburg UniversityCenter, Hasselt, Belgium

MedicalSchool at University of Antwerp, Antwerp, Belgium (MD)

PhD thesis: “Balance between desired and unwanted effects of chemotherapeutic and anti-angiogenic drugs” at department of Medical Oncology at the University of Groningen, The Netherlands

Degree: Medical Oncologist, University of Rotterdam, The Netherlands

Additional training

2013

2014

12th Masterclass in Clinical Oncology by the European School of

Oncology (ESO) and European Society of Medical Oncology

(ESMO)

Clinical Trial Statistics for Non-Statisticians by the European

Organization for Research and Treatment in Cancer (EORTC)

Basic Course Legislation and Organization for Clinical Researchers

(BROK)

Professional experience

2008 – 2010

2010 – 2011

2011 – present

Fellow, Dept of Medical Oncology, ErasmusMedical Center, Rotterdam, The Netherlands

Staff member, Dept of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Staff member, Dept of Medical Oncology, University of Utrecht, Utrecht, the Netherlands

Since start of PhD thesis extensive experience with clinical trials

Strategic program(s):

Contact

fvos@umcutrecht.nl

Pure profile

Research groups

Clinical and translational neuro-oncology

Research aim

We aim to improve treatments and clinical outcomes of patients with gliomas and other brain tumors, by combining expertise from oncobiology, neuropsychology, imaging, surgical & clinical neurology, and palliative care.

Go to group

Recent publications

All publications

Timely integration of palliative care into oncology in hospitals in the Netherlands Carly S Heipon, Linda Brom, Wendy M van der Deure, Irene Dingemans, Olaf P Geerse, Saskia Lauer, Filip Y F L de Vos, Yvette M van der Linden, Anna K L Reyners, Natasja J H Raijmakers
BMC Health Services Research, 2025, vol. 25

Metabolic parameters on baseline and early [ 18F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma. Bernies van der Hiel, Berlinda J de Wit-van der Veen, Alfons J M van den Eertwegh, Wouter V Vogel, Marcel P M Stokkel, Marta Lopez-Yurda, Ronald Boellaard, Ellen W Kapiteijn, Geke A P Hospers, Maureen J B Aarts, Filip Y F L de Vos, Marye J Boers-Sonderen, Astrid A M van der Veldt, Jan Willem B de Groot, John B A G Haanen
EJNMMI Research, 2025, vol. 15

Imaging Proliferation of Stage IV Cutaneous Melanoma With 18F-FLT PET/CT Bernies van der Hiel, Wouter V Vogel, Alfons J M van den Eertwegh, Carmen A Vlahu, Filip Y F L de Vos, Marye J Boers-Sonderen, Marcel P M Stokkel, Else A Aalbersberg, John B A G Haanen
Clinical Nuclear Medicine, 2025, vol. 50, p.e469-e476

Recurrent glioblastoma in national guidelines on the diagnosis and treatment of gliomas Mark P. van Opijnen, Rob J.A. Nabuurs, Filip Y.F. de Vos, Mohini T.R. Ramsoedh, Joost J.C. Verhoeff, Marjolein Geurts, Marike L.D. Broekman
Brain and Spine, 2024, vol. 4

The role of molecular biomarkers in recurrent glioblastoma trials Mark P van Opijnen, Filip Y F de Vos, Edwin Cuppen, Marjolein Geurts, Sybren L N Maas, Marike L D Broekman
Medical Oncology, 2024, vol. 41

Whole genome sequencing in (recurrent) glioblastoma Mira C Hasner, Mark P van Opijnen, Filip Y F de Vos, Edwin Cuppen, Marike L D Broekman
Acta Neurochirurgica, 2024, vol. 166

External positions

Member or Chair of diverse groups - Quality of Neuro-oncology care group; Protocol rare brain tumors, glioma, spinal and brain metastas - LWNO

lid werkgroep Richtlijnen Palliatieve Zorg - coordinatie/organisatie richtlijnen rondom palliatieve zorg - NIV